Australia's Hydration Pharmaceuticals rises on strong sales
** Shares of hydration solutions provider Hydration
Pharmaceuticals Co Ltd HPC.AX rise as much as 9.1% to A$0.120,
marking their biggest intraday pct gain since May 4
** Co posts Q2 FY2022 net sales of $2.0 mln, a 42% rise on
the prior corresponding period urn:newsml:reuters.com:*:nASXbqjGYS
** Says net sales in June increased 29% in the previous
month
** As of last close, stock down 63.3% this year
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))
Recent news on Hydration Pharmaceuticals
See all newsBrief: Hydration Pharmaceuticals Launches Pro Rata Entitlement Offer To Raise Up To A$1.43 MLN
Australia's Hydration Pharmaceuticals soars on upbeat monthly sales
Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
Brief: Hydration Pharmaceuticals Announces Divesture Of Hydralyte's Non-US Assets
Brief: Hydration Pharmaceuticals Says Adem Karafili Appointed Non-Executive Chairman